We’re especially excited about this because it broadens our understanding of the buffering of large chromosomal deletions in basal breast cancer shedding light on potential targeted therapies.

We showed that chr4p loss in basal breast cancer is associated with disrupted mitochondrial respiratory function and reduced glycolytic capacity, suggesting metabolic rewiring. Increased reactive oxygen species and lipid peroxidation compromised antioxidant defense mechanisms.